03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Aryoseven RT : | |
Type | Medicine Authorised |
Note | Medicine registered upon Minister decision |
Originator | NovoSeven RT 50KIU |
Agent | Lebiran |
Distributor | Lebiran |
Laboratory | Aryogen |
Responsible Party | Aryogen Pharmed |
Origin | Iran |
Manufacturer | Aryogen Pharmed |
Manufacturing Type | G |
Origin | Iran |
ATC | B02BD08 |
Aryoseven RT :
Aryoseven RT :
Aryoseven RT :
Aryoseven RT :
Aryoseven RT :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
ALT increased | Rare |
Anaphylactic reactions | Not known |
Angina pectoris | Rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Antithrombin III decreased | Rare |
Blood alkaline phosphatase increased | Rare |
Blood lactate dehydrogenase increased | Rare |
Cardiac arrest | Not known |
Cerebral artery occlusion | Rare |
Cerebral infarction | Rare |
Cerebral ischaemia | Rare |
Cerebrovascular accident | Rare |
Coagulopathy | Rare |
Deep vein thrombosis | Uncommon |
Dermatitis allergic | Uncommon |
Disseminated intravascular coagulation | Rare |
Drug ineffective | Not known |
Fibrin D dimer increased | Rare |
Fibrin degradation products increased | Rare |
Flushing | Not known |
Headache | Rare |
Hypersensitivity | Rare |
Inhibiting antibodies | Not known |
Injection site pain | Rare |
Injection site reaction | Rare |
Intestinal ischaemia | Rare |
Intracardiac thrombus | Not known |
Myocardial infarction | Rare |
Nausea | Rare |
Peripheral artery thrombosis | Rare |
Peripheral ischaemia | Rare |
Portal vein thrombosis | Uncommon |
Prothrombin level increased | Rare |
Pruritus | Uncommon |
Pulmonary embolism | Uncommon |
Pyrexia | Uncommon |
Rash erythematous | Uncommon |
Renal artery thrombosis | Rare |
Renal vein thrombosis | Uncommon |
Skin rash | Uncommon |
Therapeutic response decreased | Uncommon |
Thromboembolic event | Uncommon |
Thromboembolism arterial | Rare |
Thromboembolism venous | Uncommon |
Thrombophlebitis | Uncommon |
Thrombophlebitis superficial | Uncommon |
Urticaria | Uncommon |
Vessel puncture site thrombosis | Uncommon |
Aryoseven RT :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Aryoseven RT MoH 10083 :
Form | Powder and solvent for solution for injection |
Packaging | Pre-filled Syringes + Vials (Type I glass) |
Package Size | 1+1 |
Strength | 1mg (50KIU) |
Public Price | 20658871.73 L.L. |
Stratum | D |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 139519/1 |
Submission date | 19/09/2019 |
Registration Year | 07/11/2019 |
Pending Year | 09/10/2019 |
Pending Reason | Incomplete file |
Price Comparison
● Country: | Lebanon | |
● Form: | Powder and solvent for solution for injection | |
● Package Size: | 1+1 | |
● Public Price: | 20658871.73 LBP | ( 20,658,871.73 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 20658871,73 LBP | ( 20,658,871.00 LBP ) |
● Pricing Date: | 13/06/2024 |
You have to register to view this info
Drop File